Education
About Us
Working with TipRanks
Follow Us
Organon (OGN)
NYSE:OGN
OGN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$8.05 - $23.10
Previous CloseN/A
Volume728.75K
Average Volume (3M)5.73M
Market Cap
$2.37B
Enterprise Value$12.30B
Total Cash (Recent Filing)$459.00M
Total Debt (Recent Filing)$8.71B
Price to Earnings (P/E)3.0
Beta0.40
Next Earnings
Aug 12, 2025EPS Estimate
0.92Next Dividend Ex-Date
May 12, 2025Dividend Yield12.78%
Share Statistics
EPS (TTM)1.02
Shares Outstanding259,956,050
10 Day Avg. Volume9,351,211
30 Day Avg. Volume5,725,953
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap5.18
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda8.20
Forecast
1Y Price Target
$16.71Price Target Upside90.75% Upside
Rating ConsensusHold
Number of Analyst Covering8
---
Organon News
---
Bulls Say, Bears Say
Bulls Say
Financial StrategyThe dividend cut frees up approximately $200 million per year in cash, which can be re-deployed towards debt repayment.
Product LaunchesNexplanon - 5-year indication expected to launch in October with management expecting to surpass $1B in sales in 2025.
Revenue GrowthOrganon & Co. reiterated revenue guidance of $6.125 billion to $6.325 billion and expects low- to mid-single digit revenue growth post-2025.
Bears Say
Business DevelopmentBusiness development likely to be muted until 2026 as the company focuses on its balance sheet.
Currency RiskSeventy-five percent of OGN revenue is ex-US, so a strengthening USD could also create a currency headwind.
Dividend ReductionOrganon plans to cut its dividend by 90%, ending a nearly 2-year investor debate.
---
Ownership Overview
0.32% Insiders
21.25% Mutual Funds
0.98% Other Institutional Investors
50.99% Public Companies and
Individual Investors
OGN FAQ
What was Organon’s price range in the past 12 months?
Organon lowest stock price was $8.05 and its highest was $23.10 in the past 12 months.
What is Organon’s market cap?
Organon’s market cap is $2.37B.
When is Organon’s upcoming earnings report date?
Organon’s upcoming earnings report date is Aug 12, 2025 which is in 95 days.
How were Organon’s earnings last quarter?
Organon released its earnings results on May 01, 2025. The company reported $1.02 earnings per share for the quarter, beating the consensus estimate of $0.894 by $0.126.
Is Organon overvalued?
According to Wall Street analysts Organon’s price is currently Undervalued.
Does Organon pay dividends?
Organon pays a Quarterly dividend of $0.019 which represents an annual dividend yield of 12.78%. See more information on Organon dividends here
What is Organon’s EPS estimate?
Organon’s EPS estimate is 0.92.
How many shares outstanding does Organon have?
Organon has 259,956,050 shares outstanding.
What happened to Organon’s price movement after its last earnings report?
Organon reported an EPS of $1.02 in its last earnings report, beating expectations of $0.894. Following the earnings report the stock price went down -26.914%.
Which hedge fund is a major shareholder of Organon?
Currently, no hedge funds are holding shares in OGN
---
Organon Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$16.71 (90.75% Upside)
$16.71 (90.75% Upside)
Blogger Sentiment
Bullish
OGN Sentiment 90%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 2.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $550.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-52.95%
12-Months-Change
Fundamentals
Return on Equity
254.24%
Trailing 12-Months
Asset Growth
10.64%
Trailing 12-Months
Company Description
Organon
Organon (OGN) is a global healthcare company that focuses on improving the health and well-being of women. The company operates in the pharmaceuticals sector and offers a diverse portfolio of products primarily targeting reproductive health, heart disease, dermatology, and non-opioid pain management. Organon is dedicated to delivering impactful medicines and solutions, with a strong emphasis on women's health products, biosimilars, and established brands.
---
OGN Company Deck
---
OGN Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of strong growth in certain key products and segments, alongside challenges such as revenue decline due to loss of exclusivity and pricing pressures. The company's focus on cost efficiency and deleveraging initiatives is aimed at strengthening its financial position. While there are positive developments such as the successful launch and growth of certain products, the financial challenges and external pressures balance the overall sentiment.Read More>---
OGN Stock 12 Month Forecast
Average Price Target
$16.71
▲(90.75% Upside)
Technical Analysis
---